Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prapela’s SVS hospital bassinet pad is the first and only FDA De Novo authorized medical device to treat neonatal opioid withdrawal syndrome in newborns exposed to opioids before birth. Clinical studies have shown that the SVS pad can improve respiratory rhythm and reduce symptoms associated with NOWS. The company is also conducting clinical trials on a new incubator pad aimed at reducing apnea and hypoxia in preterm infants, with ongoing collaborations at Tufts Medical Center and University of Alabama at Birmingham[2][3][5][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prapela.